T1	Participants 58 84	duodenal ulcer recurrence-
T2	Participants 203 237	patients with duodenal ulcer(Du) u
T3	Participants 297 318	190 patients with DU.
T4	Participants 1565 1581	patients with DU
T5	Participants 1479 1505	42 patients with H. pylori
T6	Participants 1309 1359	group-one consisting of 31 patients with H. pylori
T7	Participants 1179 1232	two groups according to the eradication of H. pylori.
T8	Participants 1101 1123	Seventy three patients
T9	Participants 909 965	cimetidine group the omeprazole group, and the CBS group
T10	Participants 604 757	each treatment group (cometidine, omeprazole, colloidal bismuth subcitrate(CBS), CBS and metronidazole double therapy, CBS, metronidazole and amoxicillin
